| Serial Number | 79168375 |
| Word Mark | LYOPAN |
| Filing Date | Wednesday, January 14, 2015 |
| Status | 709 - CANCELLED - SECTION 71 |
| Status Date | Friday, July 8, 2022 |
| Registration Number | 4872521 |
| Registration Date | Tuesday, December 22, 2015 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 6, 2015 |
| Goods and Services | Almond oils for pharmaceutical purposes; Antibacterial pharmaceuticals; Anti-diabetic pharmaceuticals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Delivery agents in the form of dissolvable films and coatings for tablets that facilitate the delivery of nutritional supplements and of pharmaceutical preparations; Homeopathic pharmaceuticals for use in the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical antitussive-cold preparations; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for skin care; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical products for the treatment of joint disease; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, psychotropics; Pharmaceuticals, namely, anti-infectives; Amino acids for medical or veterinary purposes; Anti-infective products for veterinary use; Bacterial and bacteriological preparations for medical or veterinary purposes; Bacteriostats for medicinal, dental and veterinary use; Biochemical preparations, namely, reagents for medical and veterinary diagnostic purposes; Plant extracts for medical, veterinary and pharmaceutical purposes; Veterinary preparations, namely, pain relief medication; Veterinary preparations for treatment of intestinal bacteria; Veterinary preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders in a variety of animal; Veterinary preparations, namely, antioxidants; veterinary vaccines; health care preparations, namely, dietary supplements; Dietetic foods adapted for medical use, namely, bread, cookies and crackers; Diet capsules, Diet pills, Food for medically restricted diets, namely, pasta, crackers and candy adapted for medical use; food for babies; medical plasters; medical dressings; material for dental fillings and dental impressions; all-purpose disinfectants; Gastrointestinal cleaning agents; sanitary preparations for medical purposes; dietetic substances adapted for medical use, namely, dietetic candy; preparations for destroying vermin; fungicides; herbicides; nutritional supplements; pharmaceutical effervescent tablets for treating upset stomach and stomach disease; medicine delivery agents in the form of soft-gelatin capsules for the controlled release of active ingredients for a wide range of pharmaceutical products; medicine delivery agents in the form of powders for the controlled release of active ingredients for a wide range of pharmaceutical products; medicine delivery agents in the form of tablets for the controlled release of active ingredients for a wide range of pharmaceutical products |
| Goods and Services | Dental bleaching gels, Tooth bleaching preparations, Laundry bleach, blueing, detergent, pre-soak, sizing, soap and starch; general purpose cleaning, polishing, degreasing and abrasive liquids and powders; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices; descaling agents and descaling agents in tablet form for household use; all-purpose cleaning preparations |
| Goods and Services | Chemicals for use in industry and science; photographic chemicals; chemicals for use in agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides; unprocessed artificial resins, unprocessed plastics; soil fertilizers; fire extinguishing compositions; tempering preparations; soldering chemicals; tempering chemicals for use in soldering; chemical substances for preserving foodstuffs; tanning agents for use in the manufacture of leather; adhesives for use in industry; descaling preparations and descaling preparations in tablet form for industrial purposes |
| Translation of Words in Mark | The wording "LYOPAN" has no meaning in a foreign language. |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, July 8, 2022 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 003 - Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices. |
| US Class Codes | 001, 004, 006, 050, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, July 8, 2022 |
| Primary Code | 003 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, July 8, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Pantec AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | CH-6362 Stansstad CH |
| Party Name | Pantec AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | CH-6362 Stansstad CH |
| Party Name | Pantec AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | CH-6362 Stansstad CH |
| Event Date | Event Description |
| Tuesday, May 9, 2023 | TOTAL INVALIDATION PROCESSED BY THE IB |
| Thursday, April 20, 2023 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| Thursday, April 20, 2023 | INVALIDATION PROCESSED |
| Wednesday, March 8, 2023 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Friday, July 8, 2022 | CANCELLED SECTION 71 |
| Tuesday, December 22, 2020 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Friday, July 15, 2016 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Monday, April 11, 2016 | FINAL DISPOSITION NOTICE SENT TO IB |
| Monday, April 11, 2016 | FINAL DISPOSITION PROCESSED |
| Tuesday, March 22, 2016 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Monday, February 22, 2016 | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
| Friday, February 12, 2016 | CORRECTION TRANSACTION RECEIVED FROM IB |
| Tuesday, December 22, 2015 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, October 6, 2015 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 6, 2015 | PUBLISHED FOR OPPOSITION |
| Friday, October 2, 2015 | NOTIFICATION PROCESSED BY IB |
| Wednesday, September 16, 2015 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, September 16, 2015 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, September 16, 2015 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 1, 2015 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Friday, August 28, 2015 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, August 28, 2015 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, August 28, 2015 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, August 28, 2015 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Thursday, August 27, 2015 | NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED |
| Thursday, August 27, 2015 | ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED |
| Thursday, August 27, 2015 | ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED |
| Thursday, August 27, 2015 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, August 26, 2015 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, August 26, 2015 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Wednesday, August 5, 2015 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, August 5, 2015 | FINAL REFUSAL E-MAILED |
| Wednesday, August 5, 2015 | FINAL REFUSAL WRITTEN |
| Wednesday, August 5, 2015 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, August 5, 2015 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, August 1, 2015 | REFUSAL PROCESSED BY IB |
| Tuesday, July 28, 2015 | ASSIGNED TO LIE |
| Sunday, July 19, 2015 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, July 14, 2015 | APPLICATION FILING RECEIPT MAILED |
| Monday, July 13, 2015 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, July 13, 2015 | REFUSAL PROCESSED BY MPU |
| Sunday, July 12, 2015 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Saturday, July 11, 2015 | NON-FINAL ACTION WRITTEN |
| Friday, July 10, 2015 | ASSIGNED TO EXAMINER |
| Friday, July 10, 2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, July 9, 2015 | SN ASSIGNED FOR SECT 66A APPL FROM IB |